National Stock Number
6505-01-643-4010
National Stock Number (NSN) 6505-01-643-4010, or NIIN 016434010, (influenza virus vaccine) was assigned March 31, 2015 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 4 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Feb 08, 2016. There has been one contract issued for this part number, with 57 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP15D0003, SPE2DP15D0003, SPE2DP15D0003, SPE2DP15D0003, SPE2DP15D0003. The total value of the awarded contracts has been US$ 13,977,856.00.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Jul 30, 2016, this NSN's acquisition method was noted as: Not established. Not established.
This NSN is assigned to Item Name Code (INC) 22781. [A VACCINE INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF INFLUENZA DISEASE CAUSED BY INFLUENZA A SUBTYPE VIRUSES AND TYPE B VIRUSES CONTAINED IN THE VACCINE.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016434010 does not contain precious metals.
This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.
This information was last updated on Jul 01, 2025.